[
  {
    "ts": null,
    "headline": "Merck (MRK) Rises Higher Than Market: Key Facts",
    "summary": "In the latest trading session, Merck (MRK) closed at $100.69, marking a +1.52% move from the previous day.",
    "url": "https://finnhub.io/api/news?id=5b359bd97180e161669810c42f0d32d1fefcbe48039e19025b070aad31a73de4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1766098202,
      "headline": "Merck (MRK) Rises Higher Than Market: Key Facts",
      "id": 137831502,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "In the latest trading session, Merck (MRK) closed at $100.69, marking a +1.52% move from the previous day.",
      "url": "https://finnhub.io/api/news?id=5b359bd97180e161669810c42f0d32d1fefcbe48039e19025b070aad31a73de4"
    }
  },
  {
    "ts": null,
    "headline": "Merck's Deep Pipeline And Cash Flow Strength Support The Bull Case",
    "summary": "Merck (MRK) stock is a buy as Q3 beats estimates, driven by Keytruda, pipeline growth, and strong technicals. Read here for more analysis.",
    "url": "https://finnhub.io/api/news?id=8bf8bea4c017c639146d47ed4c8d8d2b37bd9537b4e36b0eed2c89ab716c947b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1766098022,
      "headline": "Merck's Deep Pipeline And Cash Flow Strength Support The Bull Case",
      "id": 137827670,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1210931291/image_1210931291.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Merck (MRK) stock is a buy as Q3 beats estimates, driven by Keytruda, pipeline growth, and strong technicals. Read here for more analysis.",
      "url": "https://finnhub.io/api/news?id=8bf8bea4c017c639146d47ed4c8d8d2b37bd9537b4e36b0eed2c89ab716c947b"
    }
  },
  {
    "ts": null,
    "headline": "Does Merck KGaA’s Rebound Reflect Its True Value After AI Partnership And CEO Change News",
    "summary": "Wondering if Merck KGaA is a bargain hiding in plain sight or a value trap at €118.85? This article unpacks what the market is really pricing in. The stock has slipped 0.2% over the last week, but is up 6.4% over the past month, even though it remains down 15.3% year to date and 12.6% over the last year. That rebound has come as investors refocus on Merck's diversified footprint across healthcare, life science, and electronics, and its ongoing investments into high growth areas like...",
    "url": "https://finnhub.io/api/news?id=2938020a2d1ceb92648c31452acfe9823283d4109485ae72c1db8e3432bc21c9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1766088804,
      "headline": "Does Merck KGaA’s Rebound Reflect Its True Value After AI Partnership And CEO Change News",
      "id": 137825320,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Wondering if Merck KGaA is a bargain hiding in plain sight or a value trap at €118.85? This article unpacks what the market is really pricing in. The stock has slipped 0.2% over the last week, but is up 6.4% over the past month, even though it remains down 15.3% year to date and 12.6% over the last year. That rebound has come as investors refocus on Merck's diversified footprint across healthcare, life science, and electronics, and its ongoing investments into high growth areas like...",
      "url": "https://finnhub.io/api/news?id=2938020a2d1ceb92648c31452acfe9823283d4109485ae72c1db8e3432bc21c9"
    }
  },
  {
    "ts": null,
    "headline": "3 Cancer Stocks to Buy Amid Rapid Advances in Cancer Treatment",
    "summary": "J&J, ImmunityBio and Foghorn Therapeutics stand out as oncology players amid rapid innovation in cancer care with advancing pipelines, approvals and partnerships.",
    "url": "https://finnhub.io/api/news?id=5726ca2ccdc787ed320a3850e679a9b9333a7f4ca24f8d2b6ffb615ba7be8661",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1766072400,
      "headline": "3 Cancer Stocks to Buy Amid Rapid Advances in Cancer Treatment",
      "id": 137825231,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "J&J, ImmunityBio and Foghorn Therapeutics stand out as oncology players amid rapid innovation in cancer care with advancing pipelines, approvals and partnerships.",
      "url": "https://finnhub.io/api/news?id=5726ca2ccdc787ed320a3850e679a9b9333a7f4ca24f8d2b6ffb615ba7be8661"
    }
  },
  {
    "ts": null,
    "headline": "Micron upgraded, PayPal downgraded: Wall Street's top analyst calls",
    "summary": "Micron upgraded, PayPal downgraded: Wall Street's top analyst calls",
    "url": "https://finnhub.io/api/news?id=80851fd489b1a8ffeff46255613270cc3ca8eddfc4b3249d19792f9460f25e30",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1766069418,
      "headline": "Micron upgraded, PayPal downgraded: Wall Street's top analyst calls",
      "id": 137821610,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Micron upgraded, PayPal downgraded: Wall Street's top analyst calls",
      "url": "https://finnhub.io/api/news?id=80851fd489b1a8ffeff46255613270cc3ca8eddfc4b3249d19792f9460f25e30"
    }
  },
  {
    "ts": null,
    "headline": "Here Are Thursday’s Top Wall Street Analyst Research Calls: Digital Realty, GE Vernova, Micron Technology, Merck & Co., Rivian, United Airlines, and More",
    "summary": "Pre-Market Stock Futures: Futures are trading higher on Thursday as we grind closer to the Christmas holiday, which is just a week off now. The song remains the same for the AI/Datacenter trade, and participants are finding it’s going to be a bit tougher here at the end of the year than in the last ... Here Are Thursday’s Top Wall Street Analyst Research Calls: Digital Realty, GE Vernova, Micron Technology, Merck & Co., Rivian, United Airlines, and More",
    "url": "https://finnhub.io/api/news?id=93937da14608efa8feae792246a814befc3a4723f61d2509bf3eca6f25997588",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1766065859,
      "headline": "Here Are Thursday’s Top Wall Street Analyst Research Calls: Digital Realty, GE Vernova, Micron Technology, Merck & Co., Rivian, United Airlines, and More",
      "id": 137821688,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Pre-Market Stock Futures: Futures are trading higher on Thursday as we grind closer to the Christmas holiday, which is just a week off now. The song remains the same for the AI/Datacenter trade, and participants are finding it’s going to be a bit tougher here at the end of the year than in the last ... Here Are Thursday’s Top Wall Street Analyst Research Calls: Digital Realty, GE Vernova, Micron Technology, Merck & Co., Rivian, United Airlines, and More",
      "url": "https://finnhub.io/api/news?id=93937da14608efa8feae792246a814befc3a4723f61d2509bf3eca6f25997588"
    }
  }
]